 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy AbbVie stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:ABBV! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about AbbVie stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet’s diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Volume médio
8.09 million shs
MERCADO CAP
$187.23 billion
Bolsa de Valores
NYSE
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NYSE:ABBV
|
Preparações farmacêuticas
|
Médico
|
295,561 shs
|
Below is a quick guide on how to buy NYSE:ABBV stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy AbbVie shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy AbbVie – Search for “”NYSE:ABBV”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought AbbVie stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
20 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for AbbVie in the last year. There are currently 1 sell rating, 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” AbbVie stock.
Wall Street analysts have given AbbVie a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but AbbVie wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:ABBV stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy AbbVie stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy AbbVie stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NYSE:ABBV stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NYSE:ABBV stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:ABBV is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy AbbVie stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, May 7th 2021.
View our earnings forecast for AbbVie.
AbbVie Inc. (NYSE:ABBV) posted its earnings results on Tuesday, February, 2nd. The company reported $2.92 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.85 by $0.07. The company earned $13.86 billion during the quarter, compared to the consensus estimate of $13.70 billion. AbbVie had a net margin of 18.16% and a trailing twelve-month return on equity of 439.24%. The firm’s revenue for the quarter was up 59.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.21 EPS.
View AbbVie’s earnings history.
AbbVie’s stock was trading at $84.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ABBV shares have increased by 29.1% and is now trading at $109.51.
AbbVie declared a quarterly dividend on Friday, October 30th. Investors of record on Friday, January 15th will be paid a dividend of $1.30 per share on Tuesday, February 16th. This represents a $5.20 annualized dividend and a yield of 4.75%. The ex-dividend date is Thursday, January 14th. This is a positive change from AbbVie’s previous quarterly dividend of $1.18.
View AbbVie’s dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:ABBV stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
AbbVie pays an annual dividend of $5.20 per share and currently has a dividend yield of 4.78%. ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. AbbVie has been increasing its dividend for 49 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of AbbVie is 58.17%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AbbVie will have a dividend payout ratio of 42.73% next year. This indicates that AbbVie will be able to sustain or increase its dividend.
View AbbVie’s dividend history.
AbbVie updated its FY21 earnings guidance on Wednesday, February, 3rd. The company provided earnings per share (EPS) guidance of $12.32-12.52 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.19.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
20 equities research analysts have issued 12 month price objectives for AbbVie’s stock. Their forecasts range from $95.00 to $140.00. On average, they anticipate AbbVie’s share price to reach $113.89 in the next year. This suggests a possible upside of 4.0% from the stock’s current price.
View analysts’ price targets for AbbVie or view top-rated stocks among Wall Street analysts.
AbbVie’s management team includes the following people:
Mr. Richard A. Gonzalez, Chairman & CEO (Age 67, Pay $7.11M)
Dr. Michael E. Severino, Vice Chairman & Pres (Age 55, Pay $3.98M)
Mr. Robert A. Michael, Exec. VP & CFO (Age 51, Pay $2.76M)
Ms. Laura J. Schumacher, Vice Chairman of External Affairs, Chief Legal Officer & Corp. Sec. (Age 58, Pay $4.3M)
Mr. Carlos Alban, Vice Chairman & Chief Commercial Officer (Age 58, Pay $4.08M)
Dr. Azita Saleki-Gerhardt, Exec. VP of Operations (Age 58)
Dr. Thomas J. Hudson, Sr. VP of R&D and Chief Scientific Officer (Age 59)
Ms. Elizabeth Shea, VP of Investor Relations
Mr. Timothy J. Richmond, Exec. VP & Chief HR Officer (Age 55)
Mr. Scott C. Brun M.D., VP of Scientific Affairs & Head of AbbVie Ventures
580 employees have rated AbbVie CEO Richard A. Gonzalez on Glassdoor.com. Richard A. Gonzalez has an approval rating of 88% among AbbVie’s employees.
Some companies that are related to AbbVie include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of ABBV’s competitors.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
Based on aggregate information from Reportlab watchlists, some companies that other AbbVie investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), Vermilion Energy Inc. (VET.TO) (VET), AT&T (T), Bristol-Myers Squibb (BMY), Wheaton Precious Metals Corp. (WPM.TO) (WPM), Rogers Communications (RCI) and Open Text (OTEX).
AbbVie trades on the New York Stock Exchange (NYSE) under the ticker symbol “ABBV.”
AbbVie’s stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.05%), Sumitomo Mitsui Trust Holdings Inc. (0.44%), Swiss National Bank (0.38%), California Public Employees Retirement System (0.25%), Bahl & Gaynor Inc. (0.19%) and Boston Partners (0.16%). Company insiders that own AbbVie stock include Azita Saleki-Gerhardt, Brian L Durkin, Carlos Alban, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Richard A Gonzalez, Roxanne S Austin, Timothy J Richmond and William J Chase.
View institutional ownership trends for AbbVie.
ABBV stock was sold by a variety of institutional investors in the last quarter, including AJO LP, PGGM Investments, Robeco Institutional Asset Management B.V., Sumitomo Mitsui Trust Holdings Inc., Russell Investments Group Ltd., NN Investment Partners Holdings N.V., First Trust Advisors LP, and Swiss National Bank. Company insiders that have sold AbbVie company stock in the last year include Carlos Alban, Jeffrey Ryan Stewart, Richard A Gonzalez, and Timothy J Richmond.
View insider buying and selling activity for AbbVie or view top insider-selling stocks.
ABBV stock was purchased by a variety of institutional investors in the last quarter, including Boston Partners, BlackRock Inc., Assenagon Asset Management S.A., AMF Pensionsforsakring AB, Artemis Investment Management LLP, Rhenman & Partners Asset Management AB, State of Michigan Retirement System, and California Public Employees Retirement System. Company insiders that have bought AbbVie stock in the last two years include Brian L Durkin, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Roxanne S Austin, and William J Chase.
View insider buying and selling activity for AbbVie or or view top insider-buying stocks.
Shares of ABBV can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How to buy AbbVie stocks?
The safest and easiest way to buy NYSE:ABBV stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Abrir uma conta com um desses corretores é uma atitude inteligente, eles estão ativos há mais de dez anos, são muito seguros de usar e têm a melhor plataforma para comerciantes novatos e experientes. Se o senhor quiser saber mais, sugerimos-lhe que leia nossa carta de eToro ou DeGiro guias.
Where to buy AbbVie stock?
You will first want to find a licensed broker that supports AbbVie stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:ABBV stocks in a safe and complete environment.
Is NYSE:ABBV stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:ABBV stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is AbbVie stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:ABBV is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in AbbVie stock.
How do you trade AbbVie stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for AbbVie stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:ABBV stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell AbbVie stock?
To sell your NYSE:ABBV stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best AbbVie stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:ABBV stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Top 10 Ações 5G Mais informações Ações 5G Top 10 Melhores Ações 5G Para Comprar
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
